Target intelligence / Profile preview

Serine and cysteine proteases (None universally standardized; common abbreviations include "SP" for serine protease and "CP" for cysteine protease in literature, but these are not official IUPAC abbreviations)

Target
None universally standardized; common abbreviations include "SP" for serine protease and "CP" for cysteine protease in literature, but these are not official IUPAC abbreviations
Molecular classification
Enzyme, Hydrolase, Endopeptidase, Exopeptidase (some members), Serine protease: Includes families such as chymotrypsin-like, trypsin-like, elastase-like, subtilisin-like, thrombin-like, Cysteine protease: Includes cathepsin L-like, cathepsin B-like, cathepsin F-like (papain-like)
01

Overview

Serine proteases and cysteine proteases are large families of enzymes that function as hydrolases, catalyzing the cleavage of peptide bonds in proteins using a nucleophilic serine or cysteine residue in their active site[1][3][9]. Both have diverse biological roles, including digestion, blood clotting, immune processes, and tissue remodeling[7][3][2]. Serine proteases are characterized by a catalytic triad of serine, histidine, and aspartate; cysteine proteases feature a triad or dyad with cysteine as the nucleophile[9][3][10]. Dysregulation of either class is implicated in multiple diseases (cancer, neurodegeneration, infection, inflammatory disease), making them important therapeutic targets[1][2][3]. Numerous drugs target members of each class, mainly through active site inhibition. Due to broad functional diversity, "Serine and Cysteine Proteases" refers collectively to two large, structurally distinct, but functionally overlapping enzyme families[5].

Other names
Serine peptidaseCysteine peptidaseThiol protease (for cysteine protease)Endopeptidase (for many family members)
02

Mechanism of action

Competitive inhibition of the active catalytic site; Covalent modification of the nucleophilic residue (serine or cysteine); Blockade of substrate entry; Allosteric modulation

03

Biological functions

Proteolysis (protein degradation)Signal transductionCell death (apoptosis)Cell cycle regulationImmune response (processing antigens)Blood coagulation (serine proteases)Nutrient metabolism (cysteine proteases)Extracellular matrix remodelingDevelopment and senescence
04

Disease associations

CancerNeurodegenerative disease (Alzheimer's, Parkinson's)Inflammation (emphysema, atherosclerosis)Infection (parasitic, viral)Coagulation disordersOther: autoimmune diseases, metabolic disorders
05

Safety considerations

Off-target effects (broad protease inhibition can disrupt normal physiological proteolysis)Bleeding risk (serine protease inhibitors affecting coagulation)Immunosuppression (as seen with cysteine protease inhibition in antigen processing)Toxicity due to protease accumulation or insufficient substrate breakdown
06

Interacting drugs

Protease inhibitors (e.g. aprotinin, leupeptin, camostat, E-64)

3 more in the full profile.

07

Biomarkers

Elevated levels of specific proteases in serum, urine, or tissue (e.g., Cathepsin B for cancer prognosis)D-dimer for thrombin activity (serine protease)Fibrin degradation products (coagulation)Cathepsin S activity in autoimmune/inflammatory conditions

Beyond the preview

Go deeper on Serine and cysteine proteases (None universally standardized; common abbreviations include "SP" for serine protease and "CP" for cysteine protease in literature, but these are not official IUPAC abbreviations).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine and cysteine proteases (None universally standardized; common abbreviations include "SP" for serine protease and "CP" for cysteine protease in literature, but these are not official IUPAC abbreviations).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call